[go: up one dir, main page]

EA200602104A1 - Фармацевтическая композиция, диспергируемая в ротовой полости, для оромукозального или сублингвального введения агомелатина - Google Patents

Фармацевтическая композиция, диспергируемая в ротовой полости, для оромукозального или сублингвального введения агомелатина

Info

Publication number
EA200602104A1
EA200602104A1 EA200602104A EA200602104A EA200602104A1 EA 200602104 A1 EA200602104 A1 EA 200602104A1 EA 200602104 A EA200602104 A EA 200602104A EA 200602104 A EA200602104 A EA 200602104A EA 200602104 A1 EA200602104 A1 EA 200602104A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
agomelatin
humor
dispensable
fatal
Prior art date
Application number
EA200602104A
Other languages
English (en)
Other versions
EA013751B1 (ru
Inventor
Марк Жульен
Франсуа Тарро
Жан-Манюэль Пеан
Патрик Вутрих
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36663148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200602104(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200602104A1 publication Critical patent/EA200602104A1/ru
Publication of EA013751B1 publication Critical patent/EA013751B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение касается твердой диспергируемой в ротовой полости фармацевтической композиции с покрытием для введения агомелатина оральным, оромукозальным или сублингвальным путем.
EA200602104A 2005-12-14 2006-12-13 Твердая диспергируемая в ротовой полости фармацевтическая форма агомелатина, способ получения и ее применение, применение гранул EA013751B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0512647A FR2894475B1 (fr) 2005-12-14 2005-12-14 Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine

Publications (2)

Publication Number Publication Date
EA200602104A1 true EA200602104A1 (ru) 2007-06-29
EA013751B1 EA013751B1 (ru) 2010-06-30

Family

ID=36663148

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200602104A EA013751B1 (ru) 2005-12-14 2006-12-13 Твердая диспергируемая в ротовой полости фармацевтическая форма агомелатина, способ получения и ее применение, применение гранул

Country Status (41)

Country Link
US (1) US7892575B2 (ru)
EP (1) EP1800669B1 (ru)
JP (2) JP4996225B2 (ru)
KR (3) KR20070063420A (ru)
CN (2) CN1981752B (ru)
AP (1) AP2714A (ru)
AR (1) AR058332A1 (ru)
AT (1) ATE474561T1 (ru)
AU (1) AU2006252051B2 (ru)
BR (1) BRPI0605214A (ru)
CA (1) CA2571202C (ru)
CO (1) CO5770094A1 (ru)
CR (1) CR8788A (ru)
CU (1) CU23603B7 (ru)
CY (1) CY1110824T1 (ru)
DE (1) DE602006015592D1 (ru)
DK (1) DK1800669T3 (ru)
EA (1) EA013751B1 (ru)
ES (1) ES2348994T3 (ru)
FR (1) FR2894475B1 (ru)
GE (1) GEP20084509B (ru)
GT (1) GT200600500A (ru)
HK (1) HK1101802A1 (ru)
HN (1) HN2008000874A (ru)
HR (1) HRP20100517T1 (ru)
IL (1) IL180036A0 (ru)
MA (1) MA28722B1 (ru)
MX (1) MXPA06014605A (ru)
MY (1) MY143221A (ru)
NO (1) NO20065701L (ru)
NZ (1) NZ552025A (ru)
PE (1) PE20071030A1 (ru)
PL (1) PL1800669T3 (ru)
PT (1) PT1800669E (ru)
RS (1) RS51452B (ru)
SG (1) SG133531A1 (ru)
SI (1) SI1800669T1 (ru)
TW (1) TWI327911B (ru)
UA (1) UA86622C2 (ru)
WO (1) WO2007068829A1 (ru)
ZA (1) ZA200610511B (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008008801A2 (en) * 2006-07-11 2008-01-17 Mcneil Nutritionals, Llc Solid oral dosage vitamin and mineral compositions
PT2238974E (pt) 2009-04-09 2013-07-09 E Pharma Trento Spa Granulado para a formulação de comprimidos orodispersíveis
CN101781226B (zh) * 2009-12-23 2012-03-28 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
WO2011111027A2 (en) 2010-03-11 2011-09-15 Dexcel Pharma Technologies Ltd. Oral dispersible delayed release tablet formulation
CN101836966A (zh) * 2010-05-27 2010-09-22 北京万全阳光医药科技有限公司 一种含有阿戈美拉汀的口腔崩解片
CN101991559B (zh) * 2010-11-25 2012-04-18 天津市汉康医药生物技术有限公司 一种稳定的阿戈美拉汀胶囊药物组合物
CN103429223A (zh) * 2011-01-17 2013-12-04 武田药品工业株式会社 口腔分散片
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
JP6061924B2 (ja) * 2011-10-14 2017-01-18 武田薬品工業株式会社 口腔内分散性製剤
CN103169669B (zh) * 2011-12-26 2015-06-17 中国人民解放军军事医学科学院毒物药物研究所 阿戈美拉汀包衣微丸以及可在口中分散的药物组合物
CN102552211B (zh) * 2012-02-16 2013-07-17 福建广生堂药业股份有限公司 一种阿戈美拉汀的制剂组合物及其制备方法
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR3001894A1 (fr) 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2810656B1 (en) * 2013-06-06 2017-08-02 Zentiva, a.s. Agomelatine formulations comprising agomelatine in the form of co-crystals
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
RU2733468C2 (ru) * 2014-02-07 2020-10-01 Сентар Фармасьютикалс, Инк. Полностью натуральные нетоксичные сублингвальные системы доставки лекарственных средств
CN104523639B (zh) * 2014-12-11 2017-03-22 扬子江药业集团四川海蓉药业有限公司 一种阿戈美拉汀片剂及其制备方法
US20240216299A1 (en) * 2019-12-20 2024-07-04 Lts Lohmann Therapie-Systeme Ag Transmucosal therapeutic system containing agomelatine
MX2022007332A (es) * 2019-12-20 2022-07-13 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transmucoso que contiene agomelatina.
NL2031331B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of a short-acting psychedelic compound
NL2031332B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of psychoactive compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
ATE371439T1 (de) * 2000-07-27 2007-09-15 Roquette Freres Granulat bestehend aus stärke und laktose
JP2002338500A (ja) * 2001-03-15 2002-11-27 Yamanouchi Pharmaceut Co Ltd 苦味を低減した口腔内速崩壊錠および苦み低減化方法
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
CN1981752B (zh) 2011-11-02
PL1800669T3 (pl) 2010-12-31
AU2006252051A1 (en) 2007-06-28
SI1800669T1 (sl) 2010-11-30
JP4996225B2 (ja) 2012-08-08
PE20071030A1 (es) 2007-11-17
AP2714A (en) 2013-07-31
KR20070063420A (ko) 2007-06-19
NO20065701L (no) 2007-06-15
RS51452B (en) 2011-04-30
CY1110824T1 (el) 2015-06-10
AU2006252051B2 (en) 2013-03-14
EA013751B1 (ru) 2010-06-30
ATE474561T1 (de) 2010-08-15
CN1981752A (zh) 2007-06-20
KR20080108068A (ko) 2008-12-11
KR101013667B1 (ko) 2011-02-10
HRP20100517T1 (hr) 2010-10-31
JP2007182440A (ja) 2007-07-19
JP2012092132A (ja) 2012-05-17
IL180036A0 (en) 2008-01-20
HK1101802A1 (en) 2007-10-26
NZ552025A (en) 2008-12-24
CA2571202A1 (fr) 2007-06-14
MY143221A (en) 2011-03-31
UA86622C2 (ru) 2009-05-12
CU20060243A7 (es) 2009-09-08
EP1800669A1 (fr) 2007-06-27
MA28722B1 (fr) 2007-07-02
TW200738230A (en) 2007-10-16
CN101919800A (zh) 2010-12-22
FR2894475A1 (fr) 2007-06-15
FR2894475B1 (fr) 2008-05-16
TWI327911B (en) 2010-08-01
DE602006015592D1 (de) 2010-09-02
GT200600500A (es) 2007-07-25
CU23603B7 (es) 2010-12-08
US20070134331A1 (en) 2007-06-14
DK1800669T3 (da) 2010-10-25
KR20100012858A (ko) 2010-02-08
US7892575B2 (en) 2011-02-22
GEP20084509B (en) 2008-10-10
AP2006003844A0 (en) 2006-12-31
EP1800669B1 (fr) 2010-07-21
AR058332A1 (es) 2008-01-30
CA2571202C (fr) 2012-01-10
BRPI0605214A (pt) 2007-10-09
CR8788A (es) 2008-08-21
CO5770094A1 (es) 2007-06-29
ZA200610511B (en) 2008-05-28
HN2008000874A (es) 2012-02-27
PT1800669E (pt) 2010-08-17
WO2007068829A1 (fr) 2007-06-21
MXPA06014605A (es) 2009-02-11
SG133531A1 (en) 2007-07-30
ES2348994T3 (es) 2010-12-21

Similar Documents

Publication Publication Date Title
EA200602104A1 (ru) Фармацевтическая композиция, диспергируемая в ротовой полости, для оромукозального или сублингвального введения агомелатина
DK3984528T3 (da) Farmaceutiske sammensætninger, som omfatter nilotinib
NO20075345L (no) Sublingual belagt tablett
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
TW200621313A (en) Pharmaceutical compositions
GT200800276A (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
NO20064808L (no) Orale matrixformuleringer med licarbazepin
EP1941896A4 (en) DIPEPTIDE-CONTAINING COMPOSITION FOR ORAL ADMINISTRATION
WO2005092271A8 (en) Film compositions
BR0311327A (pt) Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo
DK1971216T3 (da) Tyggegummi indeholdende styren-dien-blokcopolymerer
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
ITFI20080016A1 (it) Formulazioni farmaceutiche orali contenenti gliclazide.
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе
BRPI0518172A (pt) prevenção de infecções verticais com endoparasitas
ATE474558T1 (de) Pharmazeutische formulierungen mit irbesartan
EA200600172A1 (ru) Фармацевтическая композиция для интраназального введения пирибедила
UY30005A1 (es) Composicion farmaceutica orodispersable para la administracion oral/mucosa o sublingual de la agomelatina.
ITMI20040621A1 (it) Composizioni farmaceutiche orali
ES1059240Y (es) Protector de mucosa oral para aplicaciones ortodoncicas.
ITRM20060710A1 (it) Dispositivo di supporto per la correzione dell'ipercifosi.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU